Article
Studies of glucocorticord resistance in chronic lymphocytic leukaemia
2012-01-01
Abstract excerpt
Glucocorticoids represent an important component of modern treatment regimens for patients with fludarabine-refractory or TP53-defective chronic lymphocytic leukaemia. However, not all patients respond to GC therapy. This in-vitro study / investigated-the molecular mechanisms responsible for GC resistance in a cohort / / of 46 primary CLL samples. As expected, dexamethasone-induced killing was more pronounced in c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 783eab91-3ac9-5fbf-b7d6-5aa848868765
- DOI
- 10.17638/03062835
